UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2)

Molecular biology reports, 2024-12, Vol.51 (1), p.671, Article 671

2024

Volltextzugriff (PDF)

EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.236-236, Article 236

2024

Volltextzugriff (PDF)

Exploring the nexus of nuclear receptors in hematological malignancies

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.78-78, Article 78

2024

Volltextzugriff (PDF)

Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.238-238, Article 238

2024

Volltextzugriff (PDF)

HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.219, Article 219

2024

Volltextzugriff (PDF)

Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture

Molecular biology reports, 2024-12, Vol.51 (1), p.721-721

2024

Volltextzugriff (PDF)

Hsa_circ_0096157 silencing suppresses autophagy and reduces cisplatin resistance in non-small cell lung cancer by weakening the Nrf2/ARE signaling pathway

Molecular biology reports, 2024-12, Vol.51 (1), p.703

2024

Volltextzugriff (PDF)

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Epigenetics, 2024-12, Vol.19 (1), p.2357518-2357518

2024

Volltextzugriff (PDF)

Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.226-226, Article 226

2024

Volltextzugriff (PDF)

Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer

Journal of ethnopharmacology, 2024-09, Vol.331, p.118265-118265, Article 118265

2024

Volltextzugriff (PDF)

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism

Biomaterials, 2024-09, Vol.309, p.122609, Article 122609

2024

Volltextzugriff (PDF)

Boric acid Increases Susceptibility to Chemotherapy by Targeting the Ferritinophagy Signaling Pathway in TMZ Resistant Glioblastoma Cells

Biological trace element research, 2024-08, Vol.202 (8), p.3574-3587

2024

Volltextzugriff (PDF)

Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer

Free radical biology & medicine, 2024-08, Vol.220, p.288-300

2024

Volltextzugriff (PDF)

Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer

Free radical biology & medicine, 2024-08, Vol.220, p.125-138

2024

Volltextzugriff (PDF)

A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8

Gene, 2024-07, Vol.916, p.148449-148449, Article 148449

2024

Volltextzugriff (PDF)

PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma

International journal of cancer, 2024-07, Vol.155 (2), p.203-210

2024

Volltextzugriff (PDF)

Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance

Life sciences (1973), 2024-07, Vol.349, p.122720, Article 122720

2024

Volltextzugriff (PDF)

Sequential development of diffuse panbronchiolitis and myasthenia gravis after thymectomy for thymic neoplasm: a case report

BMC pulmonary medicine, 2024-07, Vol.24 (1), p.1-7, Article 310

2024

Volltextzugriff (PDF)

Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy

Cellular signalling, 2024-07, Vol.119, p.111166-111166, Article 111166

2024

Volltextzugriff (PDF)

The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance

International journal of cancer, 2024-07, Vol.155 (1), p.7-18

2024

Volltextzugriff (PDF)

USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis

Anti-cancer drugs, 2024-07, Vol.35 (6), p.483-491

2024

Volltextzugriff (PDF)

CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway

Cellular signalling, 2024-07, Vol.119, p.111164-111164, Article 111164

2024

Volltextzugriff (PDF)

Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway

Phytomedicine (Stuttgart), 2024-07, Vol.129, p.155714-155714, Article 155714

2024

Volltextzugriff (PDF)

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials

Hematological oncology, 2024-07, Vol.42 (4), p.e3290-n/a

2024

Volltextzugriff (PDF)

NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges

Life sciences (1973), 2024-07, Vol.348, p.122684-122684, Article 122684

2024

Volltextzugriff (PDF)

1 – 25 von 41.545

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37.880)
Mit Volltextzugriff
(35.302)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(38.935)
Science & Technology
(36.761)
Life Sciences & Biomedicine
(34.346)
Oncology
(17.437)
Female
(15.403)
Cell Line, Tumor
(15.300)
Animals
(14.024)
Drug Resistance, Neoplasm
(13.259)
Antineoplastic Agents - Pharmacology
(11.211)
Drug Resistance, Neoplasm - Drug Effects
(11.181)
Biological And Medical Sciences
(10.188)
Drug Resistance
(9.921)
Medical Sciences
(9.789)
Male
(9.411)
Apoptosis - Drug Effects
(8.987)
Mice
(8.417)
Apoptosis
(7.557)
Chemotherapy
(7.404)
Drug Resistance, Neoplasm - Genetics
(7.341)
Tumors
(7.254)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(41.505)
EZB Electronic Journals Library
(23.174)
Ingenta.com
(19.713)
Journals@Ovid Full Text
(13.770)
IngentaConnect Journals
(11.235)
NUS Single-Journal Subscriptions
(7.543)
Elsevier ScienceDirect Journals Complete
(7.433)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(6.087)
SpringerLink
(4.899)
Wiley-Blackwell Journals
(4.418)
Springer Nature - Connect here FIRST to enable access
(3.132)
Wiley Online Library Full Collection 2018
(3.077)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.868)
Nexis Uni
(2.143)
Taylor & Francis Journals Auto-Holdings Collection
(2.121)
Taylor & Francis
(1.922)
Taylor & Francis:Master (3349 titles)
(1.566)
Oxford journals
(1.515)
Oxford Journals 2020 Medicine
(1.092)
SAGE Journals
(531)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2)

EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3

Exploring the nexus of nuclear receptors in hematological malignancies

Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors

HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture

Hsa_circ_0096157 silencing suppresses autophagy and reduces cisplatin resistance in non-small cell lung cancer by weakening the Nrf2/ARE signaling pathway

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol

Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism

Boric acid Increases Susceptibility to Chemotherapy by Targeting the Ferritinophagy Signaling Pathway in TMZ Resistant Glioblastoma Cells

Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer

Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer

A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8

PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma

Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance

Sequential development of diffuse panbronchiolitis and myasthenia gravis after thymectomy for thymic neoplasm: a case report

Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy

The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance

USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis

CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway

Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials

NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges

Suchergebnisse filtern